Next Article in Journal

Preclinical Immunogenicity and Efficacy of a Multiple Antigen-Presenting System (MAPS^TM) SARS-CoV-2 Vaccine

Next Article in Special Issue

Evaluation of Safety and Immunogenicity of BNT162B2 mRNA COVID-19 Vaccine in IBD Pediatric Population with Distinct Immune Suppressive Regimens

Previous Article in Journal

Rare Adverse Events Associated with BNT162b2 mRNA Vaccine (Pfizer-BioNTech): A Review of Large-Scale, Controlled Surveillance Studies

Previous Article in Special Issue

Cellular Immunity—The Key to Long-Term Protection in Individuals Recovered from SARS-CoV-2 and after Vaccination

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.

Search for Articles:

Title / Keyword

Author / Affiliation / Email

Journal

Article Type

Advanced Search

Section

Special Issue

Volume

Issue

Number

Page

Logical OperatorOperator

Search Text

Search Type

Submit to this Journal Review for this Journal Propose a Special Issue

Article Menu

Share Help Cite Discuss in SciProfiles

Open AccessReview

Article Versions Notes

Vaccines 2022, 10(7), 1068; https://doi.org/10.3390/vaccines10071068

Action	Date	Notes	Link
article pdf uploaded.	3 July 2022 08:56 CEST	Version of Record	https://www.mdpi.com/2076-393X/10/7/1068/pdf-vor
article xml file uploaded	6 July 2022 11:30 CEST	Original file	-
article xml uploaded.	6 July 2022 11:30 CEST	Update	https://www.mdpi.com/2076-393X/10/7/1068/xml
article pdf uploaded.	6 July 2022 11:30 CEST	Updated version of record	https://www.mdpi.com/2076-393X/10/7/1068/pdf
article html file updated	6 July 2022 11:31 CEST	Original file	-
article html file updated	12 August 2022 23:59 CEST	Update	https://www.mdpi.com/2076-393X/10/7/1068/html

Back to TopTop